Teva Pharma (TEVA) PT Raised to $8 at Piper Sandler
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $36.77 +0.68%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst David Amsellem raised the price target on Teva Pharma (NYSE: TEVA) to $8.00 (from $7.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Teva Pharma (TEVA) PT Raised to $42 at Barclays
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
